Recurrent Invasive Clear Cell Subtype of Upper Tract
Urothelial Carcinoma Responding to Enfortumab
Vedotin and Pembrolizumab After Chemotherapy: A
Case Report

doi:10.56434/j.arch.esp.urol.20267906.122

Recurrent Invasive Clear Cell Subtype of Upper Tract Urothelial Carcinoma Responding to Enfortumab Vedotin and Pembrolizumab After Chemotherapy: A Case Report

Kota Kawase, Keita Nakane, Koji Iinuma, Tomoki Taniguchi, Masayuki Tomioka, Yuki Tobisawa, Chiemi Saigoh, Tatsuhiko Miyazaki, Takuya Koie

PDF(1902 KB)

Archivos Españoles de Urología ›› 2026, Vol. 79 ›› Issue (6) : 1072-1077. DOI: 10.56434/j.arch.esp.urol.20267906.122

Case Report

Recurrent Invasive Clear Cell Subtype of Upper Tract Urothelial Carcinoma Responding to Enfortumab Vedotin and Pembrolizumab After Chemotherapy: A Case Report

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2026, 79(6): 1072-1077 https://doi.org/10.56434/j.arch.esp.urol.20267906.122

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

Article Options

PDF (4 views)
Full Text ( views)

Accesses

Citation

Detail

Sections

Recommended

Disclaimer

The statements, opinions and data contained in Archivos Españoles de Urología are solely those of the individual authors and contributors and not of the journal and the editor(s). Archivos Españoles de Urología stays neutral with regard to jurisdictional claims in published maps and insitutional affiliations.

　　Terms & Conditions　　 Terms & Use　　　 Privacy Policy　

Please choose a citation manager

Content to export

HeighLight

Abstract

Key words

Cite this article

{{custom_sec.title}}

{{custom_sec.title}}

References

References

{{custom_ack.title_en}}

Funding

RIGHTS & PERMISSIONS

Journal Info

For Authors

For Reviewers

Articles